Vitae Pharmaceuticals, Inc
DelistedCIK 1157602fmd_0J6JGXKXBJHXN9EEKA7H5JWHYHManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Jun 30, 2016, 15 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|
| Total revenues | 22 | 23 | 9 | 1 |
| Research and development | 16 | 15 | 19 | 36 |
| Total operating expenses | 21 | 20 | 27 | 45 |
| Operating income | 2 | 2 | (19) | (44) |
| Interest expense | 2 | 1 | 1 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | (1) | (1) | (1) | 0 |
| Income tax expense | – | 0 | 0 | 0 |
| Net income | 0 | 1 | (19) | (44) |
| Net income to common shareholders | – | – | (19) | (44) |